Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrika S H Simonsson

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2006
In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamicsEmma Boström, Ulrika S H Simonsson, Margareta Hammarlund-Udenaes
Journal of Pharmaceutical Sciences|March 31, 2005
Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833Emma Boström, Ulrika S H Simonsson, Margareta Hammarlund-Udenaes
The AAPS Journal|November 26, 2014
Performance of nonlinear mixed effects models in the presence of informative dropoutMarcus A Björnsson, Lena E Friberg, Ulrika S H Simonsson
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methodsRobin J Svensson, Stephen H Gillespie, Ulrika S H Simonsson
Frontiers in Veterinary Science|April 8, 2017
Residual Spinal Cord Compression Following Hemilaminectomy and Mini-Hemilaminectomy in Dogs: A Prospective Randomized StudyGustaf Svensson, Ulrika S H Simonsson, Fredrik Danielsson, et al.
Journal of Clinical Pharmacology|May 14, 2015
Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment studySiv Jönsson, Ulrika S H Simonsson, Raymond Miller, et al.
Nature Communications|December 16, 2017
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactionsSebastian G Wicha, Chunli Chen, Oskar Clewe, et al.
European Journal of Clinical Pharmacology|January 27, 2015
A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells--using rifampicin as an exampleOskar Clewe, Sylvain Goutelle, John E Conte, et al.
The AAPS Journal|June 23, 2018
Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design RecommendationsChunli Chen, Sebastian G Wicha, Rikard Nordgren, et al.
Rapid Communications in Mass Spectrometry : RCM|October 7, 2004
The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissueEmma Boström, Britt Jansson, Margareta Hammarlund-Udenaes, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2006
In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamicsEmma Boström, Ulrika S H Simonsson, Margareta Hammarlund-Udenaes
Journal of Pharmaceutical Sciences|March 31, 2005
Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833Emma Boström, Ulrika S H Simonsson, Margareta Hammarlund-Udenaes
The AAPS Journal|November 26, 2014
Performance of nonlinear mixed effects models in the presence of informative dropoutMarcus A Björnsson, Lena E Friberg, Ulrika S H Simonsson
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methodsRobin J Svensson, Stephen H Gillespie, Ulrika S H Simonsson
Frontiers in Veterinary Science|April 8, 2017
Residual Spinal Cord Compression Following Hemilaminectomy and Mini-Hemilaminectomy in Dogs: A Prospective Randomized StudyGustaf Svensson, Ulrika S H Simonsson, Fredrik Danielsson, et al.
Journal of Clinical Pharmacology|May 14, 2015
Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment studySiv Jönsson, Ulrika S H Simonsson, Raymond Miller, et al.
Nature Communications|December 16, 2017
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactionsSebastian G Wicha, Chunli Chen, Oskar Clewe, et al.
European Journal of Clinical Pharmacology|January 27, 2015
A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells--using rifampicin as an exampleOskar Clewe, Sylvain Goutelle, John E Conte, et al.
The AAPS Journal|June 23, 2018
Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design RecommendationsChunli Chen, Sebastian G Wicha, Rikard Nordgren, et al.
Rapid Communications in Mass Spectrometry : RCM|October 7, 2004
The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissueEmma Boström, Britt Jansson, Margareta Hammarlund-Udenaes, et al.
Pageof 11